NS-200

N/A

Report date: 2025/03/10 10:30:55
NME

Base Information

Drug NameNS-200
Drug Alias NameNS-200
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGalanin receptor type 2 agonists
TargetsGalanin receptor type 2
Therapy Area/IndicationsNeurogenic Bowel
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuracle Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuracle Science Co Ltd
Inactive CompaniesN/A
Active IndicationsNeurogenic Bowel
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A